This Week in Science

In Science Translational Medicine this week, a team from Northwestern University reports on the use of a novel nanoparticles to deliver therapeutic RNAi agents into brain tumors in mice. Called spherical nucleic acids, the nanoparticles are essentially gold cores surrounded by a dense shell of highly oriented DNA or RNA. In the study, the researchers were able to use SNAs to carry siRNAs against a key oncogene into tumors in mouse models, where they knocked down their target and killed off cancer cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Science

Make Them Glow

This Week in Science

This Week in Science

This Week in Nature

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.